In Brief: Preamendment Class III device reg
This article was originally published in The Gray Sheet
Executive Summary
Preamendment Class III device reg: FDA publishes proposal June 18 to retain in Class III three preamendment Class III products -- lung water monitors, powered vaginal muscle stimulators for therapeutic use, and stair-climbing wheelchairs. Written comments are due Sept. 16. Summaries of and citations to safety and effectiveness data on the devices were due at FDA in August 1996. Based on "the lack of safety and effectiveness data submitted in response" to the call for data, FDA concludes that insufficient information exists to reclassify the products...
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.